Edwards Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
Edwards Lifesciences has a total shareholder equity of $9.6B and total debt of $597.5M, which brings its debt-to-equity ratio to 6.2%. Its total assets and total liabilities are $13.0B and $3.4B respectively. Edwards Lifesciences's EBIT is $1.9B making its interest coverage ratio -28.5. It has cash and short-term investments of $4.4B.
Key information
6.2%
Debt to equity ratio
US$597.50m
Debt
| Interest coverage ratio | -28.5x |
| Cash | US$4.45b |
| Equity | US$9.61b |
| Total liabilities | US$3.36b |
| Total assets | US$12.97b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EWL's short term assets ($6.7B) exceed its short term liabilities ($1.9B).
Long Term Liabilities: EWL's short term assets ($6.7B) exceed its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: EWL has more cash than its total debt.
Reducing Debt: EWL's debt to equity ratio has reduced from 15.6% to 6.2% over the past 5 years.
Debt Coverage: EWL's debt is well covered by operating cash flow (135%).
Interest Coverage: EWL earns more interest than it pays, so coverage of interest payments is not a concern.